News

Back

GRAFTYS achieves CE recertification and MDSAP certification for Australia, Brazil, Canada and USA

October 6th 2020

BioPark

GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, is pleased to announce the CE recertification in Europe and the certification of its Quality Management System in conformity with the Medical Device Single Audit Program (MDSAP) in Australia, Brazil, Canada and the United States of America for the Design, Manufacture and Distribution of its Sterile Calcium Phosphate Resorbable Bone Void Fillers and related Delivery Systems. Discover the press release here.